This research peptide blend contains CJC-1295 without DAC (5mg) and Ipamorelin (5mg) for a combined 10mg per vial. CJC-1295 is a tetra-substituted synthetic analog of growth hormone-releasing hormone (GHRH), and Ipamorelin is a synthetic pentapeptide with selective GHS-R1a receptor affinity. Together, these compounds are studied in non-clinical in vitro models for their interaction with GHRH and GHS receptor binding kinetics, intracellular signaling pathway dynamics, and endocrine cascade activity in controlled research environments.
For in vitro laboratory research use only. Not for human or animal use.
This product is intended strictly for laboratory research use only.
It is not for human consumption, diagnosis, treatment, or therapeutic use.
By purchasing, you confirm that the product will be used exclusively for lawful research.